Kerrigan Dennis Francis 4
4 · HANOVER INSURANCE GROUP, INC. · Filed Feb 26, 2026
Research Summary
AI-generated summary of this filing
Hanover (THG) EVP Dennis F. Kerrigan Receives Stock Awards
What Happened
Dennis F. Kerrigan, Executive Vice President of Hanover Insurance Group (THG), was reported as receiving a total of 9,290 shares/units on Feb 24, 2026 through grant/award transactions recorded at $0.00 (total reported value $0). The items consist of performance-based restricted stock units (PBRSUs), restricted stock units (RSUs), and a derivative award. One PBRSU award’s performance was certified at 150% of target and another at 100% (both as adjusted for accumulated dividend equivalents); the awards remain subject to time-based vesting and are scheduled to vest on Feb 27, 2026.
Key Details
- Transaction date: Feb 24, 2026; Form 4 filed Feb 26, 2026 (filed within the typical 2‑business‑day window).
- Reported acquisitions (all at $0.00): 1,730; 1,115; 1,117; and 5,328 shares/units — total 9,290. The 5,328 item is reported as a derivative acquisition.
- Shares owned after transaction: not specified in the Form 4.
- Footnotes from the filing:
- F1: PBRSUs granted Feb 27, 2023 were certified at 150% of target (as adjusted) and vest Feb 27, 2026 (time-based vesting remains).
- F2: PBRSUs granted Feb 27, 2023 were certified at 100% of target (as adjusted) and vest Feb 27, 2026.
- F3: RSUs vest on the third anniversary of the grant (Feb 27, 2026).
- F4: Options (if applicable) vest one‑third on each of the first three anniversaries of the grant date.
- No 10b5‑1 plan, tax‑withholding sale, or late filing flag is noted in the filing.
Context
These are compensation awards and performance‑based vesting certifications, not open‑market purchases or sales. Awards that vest after performance certification reflect company compensation and recognition of achieved metrics (e.g., adjusted ROE and relative TSR) and do not by themselves indicate insider buying or selling intent. Vesting is scheduled for Feb 27, 2026 (or per the stated multi‑year vesting schedules).
Insider Transaction Report
- Award
Common Stock
[F1]2026-02-24+1,730→ 11,487.585 total - Award
Common Stock
[F2]2026-02-24+1,115→ 12,602.585 total - Award
Common Stock
[F3]2026-02-24+1,117→ 13,719.585 total - Award
Common Stock Option (right to buy)
[F4]2026-02-24+5,328→ 5,328 totalExercise: $173.56Exp: 2036-02-24→ Common Stock (5,328 underlying)
Footnotes (4)
- [F1]On February 27, 2023, the Reporting Person was granted performance-based restricted stock units ("PBRSUs") pursuant to the Issuer's 2022 Long-Term Incentive Plan ("2022 LTIP"). These PBRSUs were subject to a performance-based vesting condition related to three-year average adjusted return on equity and a time-based vesting condition, and also provided for the accumulation of dividend equivalent rights. On February 24, 2026, the performance condition for this award was certified at 150% of the target award (as adjusted for accumulated dividend equivalent rights). This award remains subject to the time-based vesting condition and will vest on February 27, 2026.
- [F2]On February 27, 2023, the Reporting Person was granted PBRSUs pursuant to the Issuer's 2022 LTIP. These PBRSUs were subject to a performance-based vesting condition related to three-year relative total shareholder return and a time-based vesting condition, and also provided for the accumulation of dividend equivalent rights. On February 24, 2026, the performance condition for this award was certified at 100% of the target award (as adjusted for accumulated dividend equivalent rights). This award remains subject to the time-based vesting condition and will vest on February 27, 2026.
- [F3]Grant of restricted stock units under the Issuer's 2022 LTIP. Such units vest on the third anniversary of the date of grant.
- [F4]Such options vest as to one-third of the shares on each of the first three anniversaries of the grant date.